Glucagonoma
Educational only: videos on MedicalVideos.com are for general information and are not medical advice. Always consult your own doctor about your health.
A glucagonoma is a rare tumor of the alpha cells of the pancreas that results in the overproduction of the hormone glucagon. Alpha cell tumors are commonly associated with glucagonoma syndrome, though similar symptoms are present in cases of pseudoglucagonoma syndrome in the absence of a glucagon-secreting tumor.
This video in 30 seconds
This video explains glucagonoma, a rare tumor of the alpha cells of the pancreas that results in overproduction of the hormone glucagon. It notes that alpha cell tumors are commonly associated with glucagonoma syndrome, and that similar symptoms can occur in pseudoglucagonoma syndrome without a glucagon-secreting tumor.
Key points
- A glucagonoma is a rare tumor of the alpha cells of the pancreas
- It results in overproduction of the hormone glucagon
- Alpha cell tumors are commonly associated with glucagonoma syndrome
- Similar symptoms can occur in pseudoglucagonoma syndrome without a tumor
Video Overview
This video presents “Glucagonoma” — A glucagonoma is a rare tumor of the alpha cells of the pancreas that results in the overproduction of the hormone glucagon. Alpha cell tumors are commonly associated with glucagonoma syndrome, though similar symptoms are present in cases. Whether you are preparing for a procedure, studying the technique, or learning how a condition is assessed, the recording shows the process as it is performed in practice.
From our Endocrinology collection: Diabetes, thyroid, adrenal and hormone disorders explained — diagnosis, treatment and patient guidance. Browse all Endocrinology videos →
Educational content only — not a substitute for professional medical advice.
Medical Videos
Free medical and surgery videos for patients, students and professionals — trusted since 2007.
Founded by Dr. Mohamed Ibrahim, MD, PhD — physician-scientist.
Follow us on Facebook · Instagram
SORT BY-
Top Comments
-
Latest comments